Posts Tagged 'durable medical equipment'

Community Pharmacist Briefs Capitol Hill on Medication Therapy Management, Pharmacist Provider Status

By Kevin Schweers

Atlanta-area independent community pharmacist Jonathan Marquess, PharmD, CDE, CPT briefed Congressional staffers June 6 regarding how medication therapy management (MTM) and other pharmacist services can help patients achieve better outcomes while reducing overall health care costs.

Continue reading ‘Community Pharmacist Briefs Capitol Hill on Medication Therapy Management, Pharmacist Provider Status’

A Day in the Life of a Pharmacist – Where Doing Extraordinary Things Is Routine

By John Norton

Pharmacists are under-appreciated, judging by the design of many public and private sector prescription drug plans. These guidelines determine pharmacies’ compensation for their services and govern how they interact with patients, doctors and the plan administrators—pharmacy benefit managers (PBMs). As the representative for approximately 23,000 independent community pharmacies, the National Community Pharmacists Association (NCPA) works to raise awareness that pharmacists are much more than simply dispensers of prescription drugs.

Continue reading ‘A Day in the Life of a Pharmacist – Where Doing Extraordinary Things Is Routine’

Proven Cure for the Common Cold: Vick’s Vapor Rub and a #2 Lead Pencil

By Gabe Trahan, Senior Director of Store Operations and Marketing

(@ncpagabe on Twitter)

Have you ever thought something was working based on a myth? Continue reading ‘Proven Cure for the Common Cold: Vick’s Vapor Rub and a #2 Lead Pencil’

Are Diabetic Shoe Sales at Community Pharmacies Facing More Medicare Audits?

Most independent community pharmacies provide durable medical equipment (DME), like diabetes testing supplies, to meet essential health needs while partially offsetting diminishing prescription drug reimbursement. About one out of every three pharmacies that offer these test kits also stock therapeutic shoes for diabetics and these pharmacies may soon face more demanding audits by Medicare contractors.

For years, the Centers for Medicare & Medicaid Services (CMS) appeared to consider a signed certifying statement by a physician as sufficient evidence to support a claim for reimbursement for therapeutic shoes.

More recently, NCPA members noticed that Medicare Administrative Contractors (MACs) seemingly altered their auditing practices and began to seek recoupment of reimbursements, even in instances in which the supplier produced a signed certifying physician statement.  Instead the MACs began demanding that the pharmacy produce medical records from the physician to match the information on the certifying statement or written order.

NCPA is asking CMS to reevaluate this situation, which has the potential to undermine patient access to these products as pharmacies choose to stop offering them because of the burdensome auditing requirements that they now face.

What follows are excerpts from a letter NCPA sent to the agency:

“Requiring suppliers, such as independent community pharmacies, to obtain medical records from physicians imposes a significant administrative burden on small business suppliers, as well as physicians.  Physicians now want to know why their signature on the certifying statement is no longer sufficient and are resistant to the extra effort required to meet supplier requests for physician records.  Given the administrative burdens, these physicians may be reticent to provide future referrals to the suppliers.

“Presently, some suppliers have indicated that the new administrative burden is too much for them and that they may decide to stop providing therapeutic shoes. As a result, patients are either forced to obtain their therapeutic shoes from other suppliers, or simply refrain from obtaining the shoes.  In the latter situation, in the end, all too often these fragile, high risk patients go from needing therapeutic shoes to developing even more serious lower extremity complications.

______

“The bottom line is that suppliers are put in the untenable position of being asked to provide care without knowing whether the physician’s records provide adequate documentation or whether the supplier will be able to obtain those records. … We urge CMS to revert to its original enforcement policy of accepting the signed and dated certifying statement as sufficient documentation for the provision of therapeutic shoes and inserts.  Without this change in policy, many suppliers will cease to provide therapeutic shoes, patients will lose access to those necessary medical supplies and patient diabetic health outcomes will suffer.”

How Will the 340B Program’s Growth Affect Community Pharmacies?

By Kevin Schweers

Since its creation in 1992, the 340B discount prescription drug program has continued to expand and provisions in the new health care reform law, as well as a “tax extenders” bill pending in Congress, will grow the 340B program’s reach further still. What does it mean for independent community pharmacies?

Continue reading ‘How Will the 340B Program’s Growth Affect Community Pharmacies?’

Preserving Access to Diabetes Testing Supplies at Community Pharmacies

By Kevin Schweers

Community pharmacists on the front lines can be very powerful advocates for their profession and their patients by offering first-hand account. For example, a Montana pharmacist recently wrote what could be considered a model letter to U.S. Senator Jon Tester (D-Mont.), articulately making the case for Congress to act to allow small pharmacies to continue providing diabetes testing supplies to seniors.

Continue reading ‘Preserving Access to Diabetes Testing Supplies at Community Pharmacies’

More Pharmacy Talk with the Feds

By Kevin Schweers

Top Democrats and Republicans in Congress and other senior federal officials shared their views on issues affecting pharmacy, during the second day of NCPA’s 2010 National Legislation and Government Affairs Conference.

Continue reading ‘More Pharmacy Talk with the Feds’

A Massachusetts Monkey Wrench in Health Care Reform?

By John Coster, RPh., Ph.D.

The upset Republican win in Tuesday’s Senate race in Massachusetts calls into question the future of the health care reform legislation that consumed so much congressional effort in 2009 and into the new year. Along with it, the outlook becomes unclear for several community pharmacy priorities, despite the support of a growing consensus in Congress. Continue reading ‘A Massachusetts Monkey Wrench in Health Care Reform?’

Pressing Phamacy Issues Covered In Opinion Pages

By John Norton

(NOTE: To read all NCPA opinion pieces go to the following link.)

As the health care reform efforts kicks into overdrive, NCPA recently had three opinion pieces published advocating for patients and community pharmacies on three major issues: mandatory mail order; durable medical equipment (DME) accreditation; and Medicaid’s Average Manufacturer Price (AMP) based cuts.

Continue reading ‘Pressing Phamacy Issues Covered In Opinion Pages’

More Changes Possible to Senate Health Reform Bill

By Kevin Schweers

Recent health reform activity in the U.S. Senate could have new implications for community pharmacy.  Three new amendments, in particular, have been offered and were endorsed today by NCPA.

Continue reading ‘More Changes Possible to Senate Health Reform Bill’


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 445 other followers